Cell therapy Center

Switch

Homepage

facebook

Other Hospital CMUH APP icon

CMUH App

Department Introduction

:::

Home/

Department Introduction/

Specialty Care Sections/

Cell therapy Center

Department Introduction

On June 18, 2019, we established the cell therapy center in China Medical University Hospital to promote clinical services related to the Regulations of special Medical Techniques, and actively develop and launch a number of multi-center clinical trials related to cell therapy.

Service

Including DC, CIK, DC-CIK, GDT, DC-CIK WT1 and other cells.

Approved by the Ministry of Health and Welfare, they are used to treat a variety of cancers in the first to fourth stages, with the highest number of items in Taiwan (8 items). As of July 31, 2022, DC has received a total of 172 cases, and DC-CIK has a total of 172 cases, both ranking first in the country.

For the hose patients with staged IV cancer receiving DC therapy had 1-years and 2-years survival rate as 49.6% and 32.4% respectively.

One-year and 2-year survival rate for patients receiving DC-CIK therapy were 63.8% and 44.3% respectively. Immune cell therapy offers a first-line chance for terminal cancer patients.

Our Teams

Quick view (click to expand)

Long-Bin Jeng

Superintendent

The 3 most reputable Taiwanese physicians in liver transplant were known as “Bo Huang from the North, Long Bin from the Central Area, Chao Long from the South” by domestic media. All 3 physicians studied under Dr. Starzl, the father of liver transplants. All 3 physicians have their own characteristics and have had significant development since then. With the retirement of Professor Bo Huang Lee of National Taiwan University, the Hospitals future looks bright under the leadership of President Long Bin Cheng. In addition to having remarkable performances in liver transplants, President Cheng is also an astounding Gastroenterology, thyroid gland tumor surgeon. His contributions to organ transplant within this hospital is fundamental and undeniable.